BIOLASE to Present at Upcoming Investment Conferences in New York City

IRVINE, CA -- (MARKET WIRE) -- 06/02/08 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that CEO Jake St. Philip and CFO David Mulder are scheduled to make investor presentations at several upcoming investor conferences in New York City.

The first conference will be the FTN Midwest Health Care Conference on Tuesday, June 3, during which management will make multiple presentations throughout the day. The conference is being held at the St. Regis Hotel.

A presentation will also be made at the Needham 7th Annual Biotechnology & Medical Technology Conference on Thursday, June 12, at 9:00 am Eastern Time. The conference is being held June 11-12 at the New York Palace Hotel.

These will be followed by a presentation at the Gabelli Sixth Annual Dental & Veterinary Conference on Thursday, June 19, at 10:30 am Eastern Time. The one-day conference is being held at the Grand Hyatt Hotel.

Webcasting will only be available at the Needham conference and the Company's presentation there will be accessible by live webcast and archived for 90 days on the investor relations section of the BIOLASE website at www.biolase.com. Also available on the Company's website will be the presentation used at the conferences.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, develops, manufactures and markets lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

For further information, please contact: David Mulder Chief Financial Officer BIOLASE Technology, Inc. +1-949-361-1200

Jill Bertotti Allen & Caron +1-949-474-4300

2008-06-02 06:01:23 0374296 MARKETWIRE